Zhen Wu decoction represses renal fibrosis by invigorating tubular NRF2 and TFAM to fuel mitochondrial bioenergetics

Background: Zhen Wu Decoction (ZWD) is a prescription from the classical text Treatise on Exogenous Febrile Disease and has been extensively used to control kidney diseases since the time of the Eastern Han Dynasty. Hypothesis: We hypothesized that ZWD limits tubular fibmgenesis by reinvigorating tubular bio-energetic capacity. Study Design / Methods: A mouse model of chronic kidney disease (CKD) was established using unilateral ureteral obstruction (UUO). Three concentrations of ZWD, namely 25.2 g/kg (high dosage), 12.6 g/kg (middle dosage), and 6.3 g/kg (low dosage), were included to study the dose-effect relationship. Real-time qPCR was used to observe gene transcription in blood samples from patients with CKD. Different siRNAs were designed to study the role of mitochondrial transcription factor A (TFAM) and nuclear factor (erythmid-derived 2)-related factor 2 (NRF2) in transforming growth factor (TGF)-beta 1 induced fibmgenesis and mitochondrial damage. Results: We showed that ZWD efficiently attenuates renal function impairment and reduces renal interstitial fibrosis. TFAM and NRF2 were repressed, and the stimulator of interferon genes (STING) was activated in CKD patient blood sample. We further confirmed that ZWD activated TFAM depended on NRF2 as an important negative regulator of STING in mouse kidneys. Treatment with ZWD significantly reduced oxidative stress and inflammation by regulating the levels of oxidative phosphorylation (OXPHOS) and pro-inflammatory factors, such as interleukin-6, interleukin-1 beta, tumor necrosis factor receptor 1, and mitochondrial respiratory chain subunits. NRF2 inhibitors can weaken the ability of ZWD to increase TFAM expression and heal injured mitochondria, playing a similar role to that of STING inhibitors. Our study showed that ZWD elevates the expression of TFAM and mitochondrial respiratory chain subunits by promoting NRF2 activation, after suppressing mitochondrial membrane damage and cristae breakdown and restricting mitochondrial DNA (mtDNA) leakage into the cytoplasm to reduce STING activation. Conclusion: ZWD maintains mitochondrial integrity and improves OXPHOS which represents an innovative insight into strengthening Yang-Qi theory. ZWD limits tubular fibmgenesis by reinvigorating tubular bio-energetic capacity.

Automated summary

This study demonstrates that Zhen Wu Decoction (ZWD) reduces renal interstitial fibrosis in chronic kidney disease (CKD) by activating mitochondrial transcription factor A (TFAM) dependent on nuclear factor (erythmid-derived 2)-related factor 2 (NRF2), thereby improving renal function.